Changing Diabetes? is Novo Nordisk’s response to the global diabetes challenge. Since the company was founded in Denmark more than 95 years ago, we have been changing diabetes. Our key contribution is to discover, develop and manufacture better biological medicines and make them accessible to people with diabetes throughout the world. However, it takes more than medicine to defeat diabetes.
By partnering with patients, policymakers, healthcare professionals and non-governmental organizations we are addressing diabetes risk factors in urban areas, ensuring that people with diabetes are diagnosed earlier and that they have access to adequate care to be able to live their lives with as few limitations as possible.
?
With two-thirds of all people with diabetes living in urban areas,
cities are the frontline in the fight against diabetes. Cities
influence how people live, travel and eat; factors which all have an
impact on health. To understand the root causes of type 2 diabetes and
the social and cultural risk factors, Novo Nordisk has initiated the
Cities Changing
Diabetes program in collaboration with a range of partners.
Today, three in four people with diabetes live in low- and
middle-income countries, where many lack access to diabetes care
either because it is not available or not affordable. Novo Nordisk is
working with partners to improve the availability, accessibility,
affordability and quality of healthcare. Our largest investment in
improving access to care is through our funding of the World Diabetes
Foundation, but we also run specific corporate access
to care programs.
Today, three in four people with diabetes live in low- and
middle-income countries, where many lack access to diabetes care
either because it is not available or not affordable. Novo Nordisk is
working with partners to improve the availability, accessibility,
affordability and quality of healthcare. Our largest investment in
improving access to care is through our funding of the World Diabetes Foundation, but we also run
specific corporate access to care programmes.
Many people with diabetes do not achieve desired health outcomes,
which puts them at risk of developing diabetes-related complications.
While Novo Nordisk provides a broad portfolio of treatment options and
delivery devices, we know that it takes more than medicine for people
to live a full and healthy life with diabetes. We address this by
providing training of healthcare providers, education of people with
diabetes and engaging in advocacy for patient-centred care.
Find out if you are at risk of type 2 diabetes
